newsfilter
← Latest News
GlobeNewswire·

MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update

VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Continues to Enroll Patients NexoBrid® Manufacturing Expansion on Track; Full Operational Capacity Expected by Year-End 2025 Additional Strategic